PDS Biotechnology Corporation (PDSB) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 22.89M | 28.25M | 27.89M | 33.65M | 42.47M | 45.05M | 52.13M | 60.16M | 68.69M | 59.06M | 56.84M | 63.35M | 67.97M | 76.48M | 74.41M | 55.74M | 60.73M | 66.84M | 71.34M | 76.93M |
| Cash & Short-Term Investments | 21.66M | 26.71M | 26.2M | 31.87M | 39.98M | 41.69M | 49.75M | 57.73M | 66.63M | 56.56M | 54.25M | 60.62M | 65.2M | 73.82M | 71.64M | 52.98M | 58.88M | 65.24M | 69.74M | 74.75M |
| Cash Only | 21.66M | 26.71M | 26.2M | 31.87M | 39.98M | 41.69M | 49.75M | 57.73M | 66.63M | 56.56M | 54.25M | 60.62M | 65.2M | 73.82M | 71.64M | 52.98M | 58.88M | 65.24M | 69.74M | 74.75M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.23M | 1.54M | 1.69M | 1.77M | 2.49M | 3.36M | 2.38M | 2.43M | 2.05M | 2.49M | 2.59M | 2.73M | 2.77M | 2.66M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.78M | 2.24M | 6.81M | 6.83M | 4.56M | 304.21K | 319.34K | 334.47K | 320.6K | 335K | 349.41K | 403.3K | 475.26K | 527.53K | 475.42K | 258.19K | 308.33K | 357.7K | 407.21K | 456.34K |
| Property, Plant & Equipment | 228.57K | 243.7K | 258.83K | 273.96K | 289.08K | 304.21K | 319.34K | 334.47K | 320.6K | 335K | 349.41K | 403.3K | 475.26K | 527.53K | 475.42K | 258.19K | 308.33K | 357.7K | 407.21K | 456.34K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.55M | 2M | 6.55M | 6.55M | 4.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 24.66M | 30.49M | 34.71M | 40.48M | 47.03M | 45.36M | 52.45M | 60.5M | 69.01M | 59.39M | 57.19M | 63.75M | 68.45M | 77.01M | 74.89M | 56M | 61.04M | 67.2M | 71.75M | 77.39M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -47.56% | -32.77% | -33.83% | -33.09% | -31.85% | -23.63% | -8.28% | -5.11% | 0.81% | -22.88% | -23.63% | 13.85% | 12.14% | 14.6% | 4.37% | -27.64% | 119.87% | 117.54% | 108.3% | 285.16% |
| Total Current Liabilities | 10.15M | 9.48M | 13.33M | 11.53M | 18.27M | 17.09M | 18.34M | 15.67M | 15.06M | 13.63M | 9.15M | 7.9M | 4.13M | 9.82M | 4.84M | 4.52M | 5.02M | 3.76M | 3.58M | 4M |
| Accounts Payable | 3.65M | 3.57M | 5.18M | 4.5M | 2.86M | 1.68M | 1.3M | 3.25M | 6M | 6.98M | 5.37M | 4.41M | 2.07M | 1.22M | 2.04M | 1.88M | 2.75M | 1.31M | 1.45M | 2.38M |
| Days Payables Outstanding | - | - | - | - | - | 9.08K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 5.21M | 5.13M | 6M | 5.5M | 12.5M | 12.5M | 12.5M | 10.42M | 7.29M | 4.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 453.63K | 271.74K | 1.47M | 493.98K | 640.07K | 663.4K | 3.1M | 0 | 418.45K | 1.29M | 1.79M | 1.27M | 1.08M | 0 | 0 | 0 | 1.23M | 729.39K | 0 | 0 |
| Current Ratio | 2.26x | 2.98x | 2.09x | 2.92x | 2.33x | 2.64x | 2.84x | 3.84x | 4.56x | 4.33x | 6.21x | 8.01x | 16.46x | 7.79x | 15.37x | 12.34x | 12.10x | 17.80x | 19.94x | 19.22x |
| Quick Ratio | 2.26x | 2.98x | 2.09x | 2.92x | 2.33x | 2.64x | 2.84x | 3.84x | 4.56x | 4.33x | 6.21x | 8.01x | 16.46x | 7.79x | 15.37x | 12.34x | 12.10x | 17.80x | 19.94x | 19.22x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 10.62M | 11.76M | 11.92M | 12.98M | 6.4M | 9.27M | 12.11M | 13.9M | 16.76M | 19.63M | 23.55M | 23.41M | 23.31M | 23.18M | 22.99M | 59.65K | 146.98K | 231.43K | 313.98K | 395.31K |
| Long-Term Debt | 10.61M | 11.73M | 11.89M | 12.94M | 6.35M | 9.2M | 12.03M | 13.81M | 16.65M | 19.51M | 23.41M | 23.25M | 23.14M | 23.02M | 22.91M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 17.67K | 25.69K | 33.52K | 41.17K | 48.66K | 61.85K | 77.66K | 93.11K | 108.21K | 122.97K | 137.4K | 151.5K | 165.29K | 164.01K | 77.13K | 59.65K | 146.98K | 231.43K | 313.98K | 395.31K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 20.77M | 21.24M | 25.25M | 24.52M | 24.67M | 26.35M | 30.45M | 29.58M | 31.82M | 33.26M | 32.7M | 31.31M | 27.44M | 33.01M | 27.83M | 4.58M | 5.17M | 3.99M | 3.89M | 4.4M |
| Total Debt | 15.86M | 16.93M | 17.97M | 18.54M | 18.96M | 21.83M | 24.67M | 24.38M | 24.11M | 23.85M | 23.6M | 23.52M | 23.51M | 23.47M | 23.36M | 394.66K | 458.29K | 490.35K | 521.69K | 552.98K |
| Net Debt | -5.8M | -9.79M | -8.23M | -13.34M | -21.02M | -19.86M | -25.08M | -33.36M | -42.53M | -32.71M | -30.65M | -37.11M | -41.69M | -50.35M | -48.28M | -52.59M | -58.42M | -64.75M | -69.22M | -74.2M |
| Debt / Equity | 4.07x | 1.83x | 1.90x | 1.16x | 0.85x | 1.15x | 1.12x | 0.79x | 0.65x | 0.91x | 0.96x | 0.72x | 0.57x | 0.53x | 0.50x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -6.43x | -5.80x | -6.83x | -3.40x | -9.38x | -6.26x | -7.83x | -6.74x | -8.02x | -8.86x | -9.15x | -12.00x | -8.99x | -59.50x | -48.38x | - | - | - | - | - |
| Total Equity | 3.89M | 9.25M | 9.45M | 15.96M | 22.36M | 19M | 22M | 30.92M | 37.18M | 26.13M | 24.48M | 32.44M | 41.01M | 44M | 47.06M | 51.43M | 55.87M | 63.21M | 67.86M | 72.99M |
| Equity Growth % | -82.59% | -51.32% | -57.03% | -48.38% | -39.86% | -27.27% | -10.14% | -4.7% | -9.33% | -40.61% | -47.97% | -36.91% | -26.6% | -30.39% | -30.65% | -29.55% | 129.23% | 132.99% | 118.72% | 329% |
| Book Value per Share | 0.07 | 0.20 | 0.20 | 0.35 | 0.55 | 0.52 | 0.60 | 0.84 | 1.07 | 0.83 | 0.79 | 1.05 | 1.35 | 1.53 | 1.65 | 1.81 | 2.14 | 2.22 | 2.39 | 3.15 |
| Total Shareholders' Equity | 3.89M | 9.25M | 9.45M | 15.96M | 22.36M | 19M | 22M | 30.92M | 37.18M | 26.13M | 24.48M | 32.44M | 41.01M | 44M | 47.06M | 51.43M | 55.87M | 63.21M | 67.86M | 72.99M |
| Common Stock | 18.42K | 18.11K | 15.74K | 15.39K | 15K | 12.54K | 12.15K | 12.14K | 12.1K | 10.92K | 10.23K | 10.19K | 10.14K | 9.96K | 9.39K | 9.39K | 9.39K | 9.39K | 9.38K | 9.38K |
| Retained Earnings | -223.96M | -216.61M | -209.04M | -200.03M | -190.6M | -182.11M | -174.16M | -163.43M | -155.1M | -144.5M | -133.6M | -122.75M | -111.22M | -101.56M | -82.42M | -75M | -69.18M | -60.7M | -54.38M | -47.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |